Basic Stats
| CIK | 1679836 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Kelvin Medical, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 13, 2018 |
KVMD / Kelvin Medical, Inc. FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THESECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-55856 Kelvin Medical, Inc. (Exact name of registrant as specified in its |
|
| May 15, 2018 |
KVMD / Kelvin Medical, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-55856 Commission File Number KELVIN MEDICAL, INC. |
|
| April 17, 2018 |
KVMD / Kelvin Medical, Inc. AW KELVIN MEDICAL, INC. 10930 Skyranch Place Nevada City, California 95959 17 April 2018 Ms. Heather Percival Ms. Amanda Ravitz United States Securities And Exchange Commission Division of Corporation Finance Mail Stop 3030 Washington, D.C. 20549 Re: Application for withdrawal of Post-Amendment No.1 to Registration Statement on Form S-1/A (SEC File No. 333-212791 - Acc-no: 0001594062-16-000723) Origi |
|
| April 12, 2018 |
EX-10.2 3 ex102.htm STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this "Agreement"), dated as of November 26, 2017, is entered into by and between Kelvin Medical, Inc. ("Seller", "KVMD", "Company:), a Nevada corporation and Gannon Giguiere ("Buyer"), an individual. Seller and Buyer are each referred to herein as a "Party" and collectively, as the "Parties." BACKG |
|
| April 12, 2018 |
KVMD / Kelvin Medical, Inc. POS AM As filed with the Securities and Exchange Commission on April, 2018 Registration No. |
|
| April 2, 2018 |
April 2, 2018 To our valued shareholders: Thanks to our friends and family who invested in Kelvin Medical, we began trading on the OTC market at the end of November 2017; our symbol is KVMD. |
|
| April 2, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 2, 2018 KELVIN MEDICAL, INC. (Exact name of Company as specified in its charter) Nevada 000-55856 81-2552488 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporati |
|
| April 2, 2018 |
KVMD / Kelvin Medical, Inc. AW KELVIN MEDICAL, INC. 10930 Skyranch Place Nevada City, California 95959 2 April 2018 Ms. Heather Percival Ms. Amanda Ravitz United States Securities And Exchange Commission Division of Corporation Finance Mail Stop 3030 Washington, D.C. 20549 Re: Application for withdrawal of Post-Amendment No.1 to Registration Statement on Form S-1/A (SEC File No. 333-212791 - Acc-no: 0001594062-16-000723) Origin |
|
| March 22, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 19, 2018 KELVIN MEDICAL, INC. (Exact name of Company as specified in its charter) Nevada 000-55856 81-2552488 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporat |
|
| March 16, 2018 |
KVMD / Kelvin Medical, Inc. / Giguiere Gannon - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Kelvin Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 488349 101 (CUSIP Number) March 14, 2018 (Date of Event Which Requires Fi |
|
| March 15, 2018 |
KVMD / Kelvin Medical, Inc. RW KELVIN MEDICAL, INC. 10930 Skyranch Place Nevada City, California 95959 15 March 2018 Ms. Heather Percival Ms. Amanda Ravitz United States Securities And Exchange Commission Division of Corporation Finance Mail Stop 3030 Washington, D.C. 20549 Re: Kelvin Medical, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed February 9, 2018 File No. 333-222950 Dear Ms. Percival: Pursuant to Rul |
|
| February 12, 2018 |
KVMD / Kelvin Medical, Inc. S-1/A As filed with the Securities and Exchange Commission on February , 2018 Registration No. |
|
| February 9, 2018 |
KVMD / Kelvin Medical, Inc. S-1 As filed with the Securities and Exchange Commission on February , 2018 Registration No. |
|
| February 5, 2018 |
EX-10.3 6 ex103.htm JANUARY 1, 2018 AGREEMEEMT FOR SERVICES WITH CONSULTANT CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made this 1st day of January 2018, between Kelvin Medical, Inc., a Nevada Corporation, and Mike Hogue, an individual (the "Consultant"). RECITALS A. The Company desires to be assured of the association and services of Consultant in order to avail itself of |
|
| February 5, 2018 |
AGREEMENT FOR MANAGEMENT SERVICES AGREEMENT FOR MANAGEMENT SERVICES AGREEMENT FOR MANAGEMENT SERVICES("Agreement"), entered into and effective as of Nov. |
|
| February 5, 2018 |
AGREEMENT TO SERVE AS CHAIRMAN OF THE BOARD AGREEMENT TO SERVE AS CHAIRMAN OF THE BOARD AGREEMENT TO SERVE AS CHAIRMAN OF THE BOARD ("Agreement"), entered into and effective as of November 15, 2016 between Kelvin Medical, Inc. |
|
| February 5, 2018 |
Equity Purchase Agreement between the Company and Phenix Ventures, LLC EQUITY PURCHASE AGREEMENT THIS EQUITY PURCHASE AGREEMENT ("Agreement") dated January 22, 2018, is made by and between KELVIN MEDICAL, INC. |
|
| February 5, 2018 |
Registrations Rights Agreement between the Company and Phenix Ventures, LLC REGISTRATION RIGHTS AGREEMENT THIS Registration Rights Agreement ("Agreement"), dated January 22, 2018, is made by and between KELVIN MEDICAL, INC. |
|
| February 5, 2018 |
KVMD / Kelvin Medical, Inc. 10-Q (Quarterly Report) 10-Q 1 form10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-55856 Commission File |
|
| January 18, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2018 KELVIN MEDICAL, INC. (Exact name of Company as specified in its charter) Nevada 000-55856 81-2552488 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorpor |
|
| January 12, 2018 |
KVMD / Kelvin Medical, Inc. POS AM POST EFFECTIVE AMENDMENT NO. 1 TO THE FORM S-1 As filed with the Securities and Exchange Commission on August 1, 2016, as amended ( File No. 333-212791) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KELVIN MEDICAL, INC. (Exact name of registrant as specified in its charter) |
|
| November 7, 2017 |
KVMD / Kelvin Medical, Inc. CERTIFICATION (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-55856 Commission File Number KELVIN MEDICAL, |
